Yarrow Bioscience (YARW) EBIT Margin (2017 - 2026)
Yarrow Bioscience (YARW) recorded EBIT Margin of -3102.00% in Q2 2026, up 4440.00 percentage points from -7542.00% a year earlier and up 714.00 percentage points from the prior quarter.
Yarrow Bioscience (YARW) EBIT Margin (2017 - 2026) Analysis & Trends
On a TTM basis, Yarrow Bioscience's EBIT Margin came in at -4712.55% as of Jun 30, 2026, up 3689.82 percentage points year-over-year; for FY2025, it was -4958.17%, up 3751.81 percentage points from FY2024.
- Annual EBIT Margin has a five-year change of -3755.17 percentage points (FY2020 to FY2025).
- Across earlier years, EBIT Margin came in at -8709.98% in FY2024 (-1809.51 pp), -6900.47% in FY2023 (-41.47 pp), -6859.00% in FY2022 (-2679.52 pp) and -4179.48% in FY2021 (-2976.48 pp).
- The Q2 2026 figure is the highest quarterly EBIT Margin since Q4 2020.
- On a year-over-year basis, EBIT Margin rose in three of the last six quarters, with an average year-over-year change of -983.92 percentage points.
- Peak year-over-year performance for EBIT Margin in the last five years was a gain of 18541.56 percentage points in Q4 2023, against a drop of 24290.74 percentage points in Q4 2022 at the low end.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,137.36 Bn | 1,105.95 Bn | 19.71 Bn | 51.16% |
| 2 | Johnson & Johnson | 617.62 Bn | 536.15 Bn | 17.26 Bn | 28.21% |
| 3 | AbbVie | 501.17 Bn | 474.28 Bn | 12.70 Bn | 37.86% |
| 4 | Merck | 368.13 Bn | 322.51 Bn | 12.21 Bn | -3.52% |
| 5 | Novartis Ag | 297.75 Bn | 261.74 Bn | 11.24 Bn | 32.97% |
| 6 | Astrazeneca | 261.23 Bn | 234.92 Bn | 12.86 Bn | 20.57% |
| 7 | Amgen | 236.68 Bn | 192.08 Bn | 7.24 Bn | 34.95% |
| 8 | Gilead Sciences | 190.97 Bn | 165.17 Bn | 6.22 Bn | -133.21% |
| 9 | Pfizer | 169.72 Bn | 116.36 Bn | 10.94 Bn | 28.37% |
| 10 | Yarrow Bioscience | 17.19 Mn | -99.31 Mn | - | -3,102.00% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -3,102.00% |
| Mar 31, 2026 | -3,816.00% |
| Jun 30, 2025 | -7,542.00% |
| Mar 31, 2025 | -4,552.97% |
| Dec 31, 2024 | -15,202.38% |
| Sep 30, 2024 | -10,819.01% |
| Jun 30, 2024 | -5,198.00% |
| Mar 31, 2024 | -7,380.00% |
| Dec 31, 2023 | -8,989.47% |
| Sep 30, 2023 | -5,468.42% |
| Jun 30, 2023 | -7,642.96% |
| Mar 31, 2023 | -5,875.00% |
| Dec 31, 2022 | -27,531.03% |
| Sep 30, 2022 | -5,588.62% |
| Jun 30, 2022 | -6,576.98% |
| Mar 31, 2022 | -4,882.58% |
| Dec 31, 2021 | -3,240.29% |
| Sep 30, 2021 | -8,095.49% |
| Jun 30, 2021 | -3,234.58% |
| Mar 31, 2021 | -4,242.17% |
Yarrow Bioscience EBIT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit-margin&ticker=YARW&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit-margin", "ticker": "YARW", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=ebit-margin&ticker=YARW&period=max&api_key=YOUR_API_KEY");
const data = await res.json();